New Horizon Health Announced 2022 Interim Report: Revenue Up 414% YoY, Gross Margin Climbs to 82% Aug 19, 2022 19:51 HKT/SGT Read More
Led by Legend Capital, Multi-omics-leading Enterprise APTBIO Closes Series B with Hundreds of Millions of CNY Aug 19, 2022 17:55 HKT/SGT Read More
Taiwan Excellence Pavilion to showcase 10 leading medical tech innovators at Medical Fair Asia 2022 Aug 19, 2022 14:00 HKT/SGT Read More
Taiwan Excellence Pavilion to showcase 10 leading medical tech innovators at Medical Fair Asia 2022 Aug 19, 2022 14:00 HKT/SGT Read More
Malaysian Genomics Explores Strategic Partnership with MAHSA Health through MoU Aug 18, 2022 18:00 HKT/SGT Read More
Essex Bio-Technology Included in "Forbes Asia's Best Under A Billion 2022" Aug 16, 2022 09:00 HKT/SGT Read More
Virios Therapeutics: The 'Virus Hypothesis' That Stands to Change the Lives of 10M Americans Aug 09, 2022 20:30 HKT/SGT Read More
Eisai and Lifenet Enter Into Capital and Business Alliance Agreement Aimed at Building Ecosystem to Reduce Burden of Medical and Nursing Care Aug 09, 2022 17:09 HKT/SGT Read More
エーザイ、「レカネマブ」について皮下注射製剤およびApoE4遺伝子型によるARIA-E発現に関するモデリング・シミュレーションに関する知見をAAIC 2022にて発表 Aug 04, 2022 10:00 JST Read More
Eisai Presents New Findings on Lecanemab's Investigational Subcutaneous Formulation and Modeling Simulation of ApoE4 Genotype on Aria-E Incidence at AAIC 2022 Aug 04, 2022 08:25 HKT/SGT Read More
Eisai and Merck & Co., Inc., Rahway, NJ, USA Provide Update on Phase 3 LEAP-002 Trial Aug 04, 2022 08:05 HKT/SGT Read More
エーザイ、レカネマブのARIA-E発現、皮下注射製剤に関する発表を含むアルツハイマー病/認知症領域の開発品に関する最新データをアルツハイマー病協会国際会議 2022にて発表 Jul 26, 2022 11:30 JST Read More